BRAIN & LinusBio Partnership Announcement Press Release LinusBio and The BRAIN Foundation Partner to Advance Biomarker-Supported Autism Diagnosis and Early Intervention LinusBio’s exposome sequencing platform will power new research initiatives; the company will offer reduced-cost testing for...
Repurposing Existing Drugs for Autism Unlocking the hidden potential of existing, FDA-approved drugs to treat autism At the BRAIN Foundation we were recently thrilled to announce a groundbreaking collaboration with Every Cure, a nonprofit organization dedicated to identifying new uses for existing...
BRAIN Foundation 5k 10k Run & 1 Mile Walk We are delighted to report that the first EVER Brain Foundation Run/Walk Fundraiser was a great success. Thank you to everyone who joined, volunteered, sponsored, donated and contributed in other ways to make this such a memorable event! The turnout...
Call for Autism Case Studies Calling all physicians! If you are a specialist treating a patient with autism with comorbidities and are using any of the next generation drugs like: MAB drugs like Humira/Enbrel/Stelara mTOR inhibitors like sirolimus and everolimus JAK inhibitors like Rinvoq and...
Synchrony 2023 Research & Clinical Presentations Recordings of Synchrony 2023 presentations now available to watch here 🎥 Synchrony 2023 was an in-person event held on Oct 20-22 at the Asilomar Conference Grounds, California, with the speaker line up that included leading academics, clinical...
JelikaLite to Launch Autism Therapy Device, Offers Early Access Waitlist JelikaLite has announced limited supply of the Cognilum device at its anticipated launch in 2024 and invites early sign-up in order to guarantee access as well as the exclusive waitlist discount. In addition, if you apply to...
Synchrony 2022 Roundtable Publication: The Role of Neuroinflammation in Behavioral Exacerbations in ASD We are glad to share that a summary paper has been published on Synchrony Symposia 2022 Roundtable: THE ROLE OF NEUROINFLAMMATION IN BEHAVIORAL EXACERBATIONS IN AUTISM SPECTRUM DISORDER. This...
The BRAIN Foundation Research Grants 2023 – Call for Applications 2023 Request for Proposals is now closed. We expect to open the next call for applications in Spring 2024. At The BRAIN Foundation, our primary focus is catalyzing basic and interdisciplinary translational research that leads...
Suramin for Autism Update: 2023 and Beyond Brought to you by the BRAIN FoundationIn partnership with PaxMedica About the event An exclusive interview with Howard Weisman, CEO of PaxMedica, on the latest developments and plans for FDA approval for suramin, a potential breakthrough treatment for...
Dedicated to our memory of Christopher Finnes and Nicholas D’Amora who inspired so many in their short but extraordinary lives Empowering Voices: A Community-Directed Panel Discussion on Epilepsy in Autism As an organization committed to serving individuals with autism, we understand the unique...
New Perspectives on Healing Chronic Diseases – a paper by Dr Naviaux In a paper published May 10, 2023 ‘Mitochondrial and metabolic features of salugenesis and the healing cycle’ Dr Robert Naviaux, professor of Medicine, Pediatrics and Pathology at UC San Diego whose work has been supported...
The BRAIN Foundation at Paxmedica’s NASDAQ Closing Bell Event It was a great honor for The BRAIN Foundation to join the PaxMedica team as they rang the NASDAQ Closing Bell last week. PaxMedica is is a clinical-stage biopharmaceutical company spearheading the development of innovative...